451 results on '"Casali, Paolo"'
Search Results
2. New targeted therapies in liposarcoma: state of art and future perspectives
3. Timeline of surgery in localized angiosarcoma of the breast: Improving outcome following multidisciplinary treatment optimization
4. Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
5. Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
6. Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
7. Solutions for optimal care and research for children and adolescents with extremely rare cancers developed within the Joint Action for Rare Cancers (JARC)
8. Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study
9. Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single Institution
10. Expectations, experiences and preferences of patients and physicians in the informed consent process for clinical trials in oncology
11. Rad52 mediates class-switch DNA recombination to IgD
12. Ethical issues in oncology practice: a qualitative study of stakeholders’ experiences and expectations
13. Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma
14. Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect?
15. The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.
16. The natural history of epithelioid sarcoma. A retrospective multicentre case-series within the Italian Sarcoma Group
17. Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial
18. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU)
19. Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
20. Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: a case series analysis and literature review
21. Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
22. Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors
23. Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
24. Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
25. Networking in rare cancers: What was done, what's next
26. Treatment challenges in and outside a network setting: Soft tissue sarcomas
27. Survival of adults with cancers of bone or soft tissue in Europe—Report from the EUROCARE-5 study
28. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial
29. 2018 ESMO Sarcoma and GIST Symposium: ‘take-home messages’ in soft tissue sarcoma
30. Global cancer control: responding to the growing burden, rising costs and inequalities in access
31. Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal Prognosis
32. Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
33. Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
34. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
35. Improving treatment results with reference centres for rare cancers: where do we stand?
36. ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review
37. Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment
38. (Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair
39. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study
40. Integrative transcriptome and chromatin landscape analysis reveals distinct epigenetic regulations in human memory B cells
41. Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers
42. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids
43. COL1A1::PDGFB fusion‐associated uterine fibrosarcoma: A case report and review of the literature.
44. Long-term disease stability with bicalutamide in a man with aggressive angiomyxoma: case report and state of art.
45. A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
46. Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard?
47. Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum
48. Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma
49. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis
50. Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.